Migräne verstehen: von der klinischen Untersuchung zu standardisierten Behandlungsstrategien

Physiotherapie spielt eine wichtige Rolle beim Management der Migräne, da eine Kombination aus medikamentöser und nicht-medikamentöser Therapie am wirksamsten ist. Um eine bestmögliche Therapie anzubieten, ist es essenziell, anhand von Assessments zu verstehen, wie und in welchen Bereichen die Migräne das Leben der Patient*innen am meisten beeinflusst. Dieser Artikel gibt einen narrativen Überblick über die aktuelle Literatur zur Migräne mit Schwerpunkt auf Diagnostik, klinischer Untersuchung, assoziierten Komorbiditäten und standardisierten Beurteilungs- und Behandlungsstrategien.

Publikationsverlauf

Artikel online veröffentlicht:
13. September 2024

• Literatur

• 1 GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018; 17: 954-976 DOI: 10.1016/S1474-4422(18)30322-3.
• 2 Steiner TJ, Stovner LJ, Vos T. Migraine is the first cause of disability in under 50 s: will health politicians now take notice?. J Headache Pain 2018; 19: 104 DOI: 10.1186/s10194-018-0846-2.
• 3 World Health Organization. Migraine and other headache disorders. (6 March 2024). Im Internet: https://bit.ly/3LQ1Il6; Stand: 01.08.2024
• 4 GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1211-1259 DOI: 10.1016/S0140-6736(17)32154-2.
• 5 Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3^rd edition (ICHD-III). Cephalalgia 2018; 38: 1-211 DOI: 10.1177/0333102417738202.
• 6 Lipton RB, Bigal ME, Diamond M. et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68: 343-349 DOI: 10.1212/01.wnl.0000252808.97649.21.
• 7 Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 1996; 119: 355-361 DOI: 10.1093/brain/119.2.355.
• 8 Thomsen AV, Ashina H, Al-Khazali HM. Clinical features of migraine with aura: a REFORM study. J Headache Pain 2024; 25: 22 DOI: 10.1186/s10194-024-01718-1.
• 9 Charles A. The evolution of a migraine attack – a review of the evidence. Headache 2013; 53: 413-419 DOI: 10.1111/head.12026.
• 10 Goadsby PJ, Holland PR, Martins-Oliveira M. et al. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev 2017; 97: 553-622 DOI: 10.1152/physrev.00034.2015.
• 11 Giffin NJ, Ruggiero L, Lipton RB. et al. Premonitory symptoms in migraine: An electronic diary study. Neurology 2003; 60: 935-940 DOI: 10.1212/01.WNL.0000052998.58526.A9.
• 12 Kelman L. The postdrome of the acute migraine attack. Cephalalgia 2006; 26: 214-220 DOI: 10.1111/j.1468-2982.2005.01026.x.
• 13 Carvalho IV, Fernandes CS, Damas DP. et al. The migraine postdrome: Clinical characterization, influence of abortive treatment and impact in the quality of life. Clin Neurol Neurosurg 2022; 221: 107408 DOI: 10.1016/j.clineuro.2022.107408.
• 14 Pietrobon D, Moskowitz MA. Pathophysiology of migraine. Annu Rev Physiol 2013; 75: 365-391 DOI: 10.1146/annurev-physiol-030212-183717.
• 15 Goadsby PJ, Holland PR, Martins-Oliveira M. et al. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev 2017; 97: 553-622 DOI: 10.1152/physrev.00034.2015.
• 16 Schulte LH, May A. Of generators, networks and migraine attacks. Curr Opin Neurol 2017; 30: 241-245 DOI: 10.1097/WCO.0000000000000441.
• 17 Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine: Current concepts and synthesis. Curr Pain Headache Rep 2003; 7: 371-376 DOI: 10.1007/s11916-003-0047-1.
• 18 Dodick DW, Silberstein SD. Central sensitization theory of migraine: clinical implications. Headache 2006; 46: S182-S191 DOI: 10.1111/j.1526-4610.2006.00602.x.
• 19 Florencio LL, de Oliveira IV, Lodovichi SS. et al. Cervical muscular endurance performance in women with and without migraine. J.Orthop Sports Phys Ther 2019; 49: 330-336 DOI: 10.2519/jospt.2019.8816.
• 20 Bevilaqua-Grossi D, Pinheiro-Araujo CF, Carvalho GF. et al. Neck pain repercussions in migraine - The role of physiotherapy. Musculoskelet Sci Pract 2023; 66: 102786 DOI: 10.1016/j.msksp.2023.102786.
• 21 Radat F. What is the link between migraine and psychiatric disorders? From epidemiology to therapeutics. Rev Neurol (Paris) 2021; 177: 821-826 DOI: 10.1016/j.neurol.2021.07.007.
• 22 Calhoun AH, Ford S, Pruitt AP. et al. The point prevalence of dizziness or vertigo in migraine and factors that influence presentation. Headache 2011; 51: 1388-1392 DOI: 10.1111/j.1526-4610.2011.01970.x.
• 23 Carvalho GF, Vianna-Bell FH, Florencio LL. et al. Presence of vestibular symptoms and related disability in migraine with and without aura and chronic migraine. Cephalalgia 2019; 39: 29-37 DOI: 10.1177/0333102418769948.
• 24 Carvalho GF, Luedtke K, Bevilaqua-Grossi D. Balance Disorders and migraine. Musculoskeletal Sci Pract 2023; 66: 102783 DOI: 10.1016/j.msksp.2023.102783.
• 25 Carvalho GF, Schwarz A, Szikszay TM. et al. Physical therapy and migraine: musculoskeletal and balance dysfunctions and their relevance for clinical practice. Braz J Phys Ther 2020; 24: 306-317 DOI: 10.1016/j.bjpt.2019.11.001.
• 26 Ashina S, Bendtsen L, Lyngberg AC. et al. Prevalence of neck pain in migraine and tension-type headache: A population study. Cephalalgia 2015; 35: 211-219 DOI: 10.1177/0333102414535110.
• 27 Florencio LL, Chaves TC, Carvalho GF, Gonçalves MC, Casimiro EC, Dach F, Bigal ME, Bevilaqua-Grossi D. Neck pain disability is related to the frequency of migraine attacks: a cross-sectional study. Headache. 2014; Jul-Aug 54: 1203-1210 DOI: 10.1111/head.12393. Epub 2014 May 26 (PMID: 24863346)
• 28 Luedtke K, Starke W, May A. Musculoskeletal dysfunction in migraine patients. Cephalalgia 2018; 38: 865-875 DOI: 10.1177/0333102417724156.
• 29 Watson DH, Drummond PD. Head pain referral during examination of the neck in migraine and tension-type. headache. Headache 2012; 52: 1226-1235 DOI: 10.1111/j.1526-4610.2012.02180.x.
• 30 Florencio LL, de Oliveira AS, Carvalho GF. et al. Cervical muscle strength and muscle co-activation during isometric contractions in patients with migraine: a cross-sectional study. Headache 2015; 55: 1312-1322 DOI: 10.1111/head.12644.
• 31 Tolentino GA, Bevilaqua-Grossi D, Carvalho GF. et al. Relationship between headaches and neck pain characteristics with neck muscle strength. J Manipulative Physiol Ther 2018; 41: 650-657 DOI: 10.1016/j.jmpt.2018.04.003.
• 32 Kurth T, Schürks M, Logroscino G. et al. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 2008; 337: a636 DOI: 10.1136/bmj.a636.
• 33 Lee MJ, Lee C, Chung C-S. The migraine–stroke connection. J Stroke 2016; 18: 146-156 DOI: 10.5853/jos.2015.01683.
• 34 Alqaqa A. The Association of Cardiovascular Disease and Migraine: Review. J Clini Exp Cardiol 2016; 7: 465 DOI: 10.4172/2155-9880.1000465.
• 35 Saeed A, Rana KF, Warriach ZI. et al. Association of migraine and ischemic heart disease: a review. Cureus 2019; 11: e5719 DOI: 10.7759/cureus.5719.
• 36 Smitherman TA, Maizels M, Penzien DB. Headache chronification: Screening and behavioral management of comorbid depressive and anxiety disorders. Headache 2008; 48: 45-50 DOI: 10.1111/j.1526-4610.2007.00974.x.
• 37 Buse DC, Silberstein SD, Manack AN. et al. Psychiatric comorbidities of episodic and chronic migraine. J Neurol 2013; 260: 1960-1969 DOI: 10.1007/s00415-012-6725-x.
• 38 Lipton RB, Hamelsky SW, Kolodner KB. et al. Migraine, quality of life, and depression: a population-based case-control study. Neurology 2000; 55: 629-635 DOI: 10.1212/wnl.55.5.629.
• 39 Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991; 37: 11-23 DOI: 10.1016/0165-1781(91)90102-u.
• 40 Benatto MT, Bevilaqua-Grossi D, Carvalho GF. et al. Kinesiophobia Is Associated with Migraine. Pain Med 2019; 20: 846-851 DOI: 10.1093/pm/pny206.
• 41 Aamodt AH, Stovner LJ, Hagen K. et al. Comorbidity of headache and gastrointestinal complaints. The Head-HUNT Study. Cephalalgia 2008; 28: 144-151 DOI: 10.1111/j.1468-2982.2007.01486.x.
• 42 Arzani M, Jahromi SR, Ghorbani Z. et al. Gut-brain axis and migraine headache: a comprehensive review. J Headache Pain 2020; 21: 15 DOI: 10.1186/s10194-020-1078-9.
• 43 McGill AT. Causes of metabolic syndrome and obesity-related co-morbidities. Part 1: a composite unifying theory review of human-specific co-adaptations to brain energy consumption. Arch Public Health 2014; 72: 30 DOI: 10.1186/2049-3258-72-30.
• 44 McCarthy LH, Bigal ME, Katz M. et al. Chronic pain and obesity in elderly people: results from the Einstein aging study. J Am Geriatr Soc 2009; 57: 15-19 DOI: 10.1111/j.1532-5415.2008.02089.x.
• 45 Pavlovic JM, Vieira JR, Lipton RB. et al. Association Between Obesity and Migraine in Women. Curr Pain Headache Rep 2017; 21: 41 DOI: 10.1007/s11916-017-0634-8.
• 46 Ford ES, Li C, Pearson WS, Zhao G. et al. Body mass index and headaches: findings from a national sample of US adults. Cephalalgia 2008; 28: 1270-1276 DOI: 10.1111/j.1468-2982.2008.01671.x.
• 47 Mattsson P. Migraine headache and obesity in women aged 40–74 years: a population-based study. Cephalalgia 2007; 27: 877-880 DOI: 10.1111/j.1468-2982.2007.01360.x.
• 48 Keith SW, Wang C, Fontaine KR. et al. BMI and headache among women: results from 11 epidemiologic datasets. Obesity (Silver Spring) 2008; 16: 377-383 DOI: 10.1038/oby.2007.32.
• 49 Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology 2006; 66: 545-550 DOI: 10.1212/01.wnl.0000197218.05284.82.
• 50 Bigal ME, Lipton RB. Putative mechanisms of the relationship between obesity and migraine progression. Curr Pain Headache Rep 2008; 12: 207-212 DOI: 10.1007/s11916-008-0036-z.
• 51 Cavestro C, Ferrero M. Migraine in Systemic Autoimmune Diseases. Endocr Metab Immune Disord Drug Targets 2018; 18: 124-134 DOI: 10.2174/1871530317666171124124340.
• 52 Do TP, Remmers A, Schytz HW. et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology 2019; 92: 134-144 DOI: 10.1212/WNL.0000000000006697.
• 53 Eigenbrodt AK, Ashina H, Khan S. et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021 17. 501-514 DOI: 10.1038/s41582-021-00509-5
• 54 Luedtke K, Boissonnault W, Caspersen N. et al. International consensus on the most useful physical examination tests used by physiotherapists for patients with headache: A Delphi study. Man Ther 2016; 23: 17-24 DOI: 10.1016/j.math.2016.02.010.
• 55 Burch RC, Loder S, Loder E. et al. The prevalence and burden of migraine and severe headache in the United States: Updated statistics from government health surveillance studies. Headache 2015; 55: 21-34 DOI: 10.1111/head.12482.
• 56 Goadsby PJ, Holland PR, Martins-Oliveira M. et al. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev 2017; 97: 553-622 DOI: 10.1152/physrev.00034.2015.
• 57 Silberstein SD, Tfelt-Hansen P, Dodick DW. et al. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 2008; 28: 484-495 DOI: 10.1111/j.1468-2982.2008.01555.x.
• 58 Hoffmann J, Recober A. Migraine and triggers: post hoc ergo propter hoc?. Curr Pain Headache Rep 2013; 17: 370 DOI: 10.1007/s11916-013-0370-7.
• 59 Buse DC, Scher AI, Dodick DW. et al. Impact of migraine on the family: Perspectives of people with migraine and their spouse/domestic partner in the CaMEO study. Mayo Clin Prc 2016; 91: 596-611 DOI: 10.1016/j.mayocp.2016.02.013.
• 60 Stokes M, Becker WJ, Lipton RB. et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: Results from the International Burden of Migraine Study (IBMS). Headache 2011; 51: 1058-1077 DOI: 10.1111/j.1526-4610.2011.01945.x.
• 61 Steiner TJ, Terwindt GM, Katsarava Z. et al. Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process. Cephalalgia 2022; 42: 1387-1396 DOI: 10.1177/03331024221110102.
• 62 Vincent M, Viktrup L, Nicholson RA. et al. The not so hidden impact of interictal burden in migraine: A narrative review. Front Neurol 2022; 13: 1032103 DOI: 10.3389/fneur.2022.1032103.
• 63 Leonardi M, Raggi A, Bussone G. et al. Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache 2010; 50: 1576-1586 DOI: 10.1111/j.1526-4610.2010.01770.x.
• 64 Mokkink LB, Terwee CB, Patrick DL. et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010; 19: 539-549 DOI: 10.1007/s11136-010-9606-8.
• 65 Luedtke K, Basener A, Bedei S. et al. Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study. BMJ Open 2020; 10: e029855 DOI: 10.1136/bmjopen-2019-029855.
• 66 Minen MT, Begasse De Dhaem O, Kroon Van Diest A. et al. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry 2016; 87: 741-749 DOI: 10.1136/jnnp-2015-312233.
• 67 Louter MA, Pijpers JA, Wardenaar KJ. et al. Symptom dimensions of affective disorders in migraine patients. J Psychosom Res 2015; 79: 458-463 DOI: 10.1016/j.jpsychores.2015.09.014.
• 68 Spitzer RL, Kroenke K, Williams JB. et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166: 1092-1097 DOI: 10.1001/archinte.166.10.1092.
• 69 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613 DOI: 10.1046/j.1525-1497.2001.016009606.x.
• 70 Bagley CL, Rendas-Baum R, Maglinte GA. et al. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache 2012; 52: 409-421 DOI: 10.1111/j.1526-4610.2011.01997.x.
• 71 Holroyd KA, Malinoski P, Davis MK. et al. The three dimensions of headache impact: Pain, disability and affective distress. Pain 1999; 83: 571-578 DOI: 10.1016/S0304-3959(99)00165-7.
• 72 Usai S, Grazzi L, D’Amico D. et al. Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy. Neurol Sci 2008; 29: 176-178 DOI: 10.1007/s10072-008-0918-1.
• 73 Stewart WF, Lipton RB, Dowson AJ. et al. Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology 2001; 56: S20-S28 DOI: 10.1212/wnl.56.suppl_1.s20.
• 74 Carvalho GF, Luedtke K, Braun T. Minimal important change and responsiveness of the Migraine Disability Assessment Score (MIDAS) questionnaire. J Headache Pain 2021; 22: 126 DOI: 10.1186/s10194-021-01339-y.
• 75 Kosinski M, Bayliss MS, Bjorner JB. et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003; 12: 963-974 DOI: 10.1023/a:1026119331193.
• 76 Pradela J, Bevilaqua-Grossi D, Chaves TC. et al. Measurement properties of the Headache Impact Test (HIT-6™ Brazil) in primary and secondary headaches. Headache 2021; 61: 527-535 DOI: 10.1111/head.14049.
• 77 Ashina M, Buse DC, Ashina H. et al. Migraine: integrated approaches to clinical management and emerging treatments. Lancet 2021; 397: 1505-1518 DOI: 10.1016/s0140-6736(20)32342-4.
• 78 Haghdoost F, Puledda F, Garcia-Azorin D. et al. Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials. Cephalalgia 2023; 43: 3331024231159366 DOI: 10.1177/03331024231159366.
• 79 Herd CP, Tomlinson CL, Rick C. et al. Botulinum toxins for the prevention of migraine in adults. Cochrane Database Syst Rev 2018; 6: CD011616 DOI: 10.1002/14651858.CD011616.pub2.
• 80 Luedtke K, Allers A, Schulte LH. Efficacy of interventions used by physiotherapists for patients with headache and migraine-systematic review and meta-analysis. Cephalalgia 2016; 36: 474-492 DOI: 10.1177/0333102415597889.
• 81 Carvalho G, Quinn R, Luedtke K. Migraine patients' experiences with and expectations from physiotherapy. Musculoskelet Sci Pract 2023; 66: 102803 DOI: 10.1016/j.msksp.2023.102803.
• 82 Luedtke K, Allers A, Schulte LH. et al. Efficacy of interventions used by physiotherapists for patients with headache and migraine-systematic review and meta-analysis. Cephalalgia 2016; 36: 474-492 DOI: 10.1177/0333102415597889.
• 83 Woldeamanuel YW, Oliveira ABD. What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials. J Headache Pain 2022; 23: 134 DOI: 10.1186/s10194-022-01503-y.
• 84 Bae JY, Sung HK, Kwon NY. et al. Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis. Medicina (Kaunas) 2021; 58: 44 DOI: 10.3390/medicina58010044.
• 85 Klan T, Gaul C, Liesering-Latta E. et al. Behavioral treatment for migraine prophylaxis in adults: Moderator analysis of a randomized controlled trial. Cephalalgia 2023; 43: 3331024231178237 DOI: 10.1177/03331024231178237.
• 86 Seng EK, Martin PR, Houle TT. Lifestyle factors and migraine. Lancet Neurol 2022; 21: 911-921 DOI: 10.1016/S1474-4422(22)00211-3.
• 87 Kropp P, Meyer B, Meyer W. et al. An update on behavioral treatments in migraine - current knowledge and future options. Expert Rev Neurother 2017; 17: 1059-1068 DOI: 10.1080/14737175.2017.1377611.
• 88 Puledda F, Shields K. Non-Pharmacological Approaches for Migraine. Neurotherapeutics 2018; 15: 336-345 DOI: 10.1007/s13311-018-0623-6.